SEC Stock Data Quick Answer Aligos Therapeutics, Inc. reported Revenue (ASC 606) of $2.19 million for fiscal year 2025. Aligos Therapeutics, Inc. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $2.19M -39.5% 2024 $3.61M -41.7% 2023 $6.19M — Quarterly Revenue (ASC 606) Quarter Ending Revenue (ASC 606) YoY QoQ September 30, 2025 … Read more
Quick Answer Aligos Therapeutics, Inc. reported Total Revenue of $2.19 million for fiscal year 2025. Aligos Therapeutics, Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $2.19M -39.5% 2024 $3.61M -41.7% 2023 $6.19M — Quarterly Total Revenue Quarter Ending Total Revenue YoY QoQ September 30, 2025 $741.0K -40.7% -23.2% June 30, … Read more
Quick Answer Aligos Therapeutics, Inc. reported Total Revenue of $2.19 million for fiscal year 2025. Aligos Therapeutics, Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $2.19M-39.5% $3.61M-41.7% $6.19M — — — Revenue (ASC 606) $2.19M-39.5% $3.61M-41.7% $6.19M — — — Net Income -$24.19M+81.6% -$131.21M-49.6% -$87.68M+8.7% -$96.05M+25.2% -$128.33M-18.2% -$108.54M-107.7% … Read more
Quick Answer ALIGN TECHNOLOGY INC reported Shares Outstanding of 71.36 million shares for fiscal year 2025. ALIGN TECHNOLOGY INC Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 71.36M -3.4% 2024 73.85M -1.6% 2023 75.08M -2.8% 2022 77.27M -1.8% 2021 78.71M -0.2% 2020 78.86M +0.5% 2019 78.43M -1.7% 2018 79.78M -0.3% 2017 … Read more
Quick Answer ALIGN TECHNOLOGY INC reported Gross Profit of $2.71 billion for fiscal year 2025. ALIGN TECHNOLOGY INC Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $2.71B -3.1% 2024 $2.80B +3.4% 2023 $2.71B +2.8% 2022 $2.63B -10.3% 2021 $2.94B +66.5% 2020 $1.76B +1.1% 2019 $1.74B +20.4% 2018 $1.45B +29.6% 2017 $1.12B … Read more
Quick Answer ALIGN TECHNOLOGY INC reported Operating Income of $545.75 million for fiscal year 2025. ALIGN TECHNOLOGY INC Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $545.75M -10.2% 2024 $607.63M -5.6% 2023 $643.34M +0.1% 2022 $642.60M -34.2% 2021 $976.40M +152.2% 2020 $387.17M -28.6% 2019 $542.49M +16.3% 2018 $466.56M +31.9% 2017 $353.61M … Read more
Quick Answer ALIGN TECHNOLOGY INC reported R&D Expense of $369.91 million for fiscal year 2025. ALIGN TECHNOLOGY INC R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $369.91M +1.6% 2024 $364.20M +5.0% 2023 $346.83M +13.6% 2022 $305.26M +21.9% 2021 $250.31M +42.8% 2020 $175.31M +11.4% 2019 $157.36M +22.1% 2018 $128.90M +32.1% 2017 $97.56M … Read more
Quick Answer ALIGN TECHNOLOGY INC reported Stockholders Equity of $4.05 billion for fiscal year 2025. ALIGN TECHNOLOGY INC Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $4.05B +5.1% 2024 $3.85B +6.1% 2023 $3.63B +0.8% 2022 $3.60B -0.6% 2021 $3.62B +12.0% 2020 $3.23B +140.2% 2019 $1.35B +7.4% 2018 $1.25B +8.5% 2017 $1.15B … Read more
Quick Answer ALIGN TECHNOLOGY INC reported Cash and Equivalents of $1.09 billion for fiscal year 2025. ALIGN TECHNOLOGY INC Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $1.09B +4.9% 2024 $1.04B +11.4% 2023 $937.44M -0.5% 2022 $942.05M -14.3% 2021 $1.10B +14.4% 2020 $960.84M +74.6% 2019 $550.42M -13.6% 2018 $636.90M … Read more
Quick Answer ALIGN TECHNOLOGY INC reported Total Assets of $6.23 billion for fiscal year 2025. ALIGN TECHNOLOGY INC Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $6.23B +0.3% 2024 $6.21B +2.1% 2023 $6.08B +2.3% 2022 $5.95B +0.1% 2021 $5.94B +23.0% 2020 $4.83B +93.1% 2019 $2.50B +21.8% 2018 $2.05B +15.0% 2017 $1.78B … Read more